Sunday, July 28, 2024 1:02:32 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent CRSP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2026 10:55:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/22/2026 10:15:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/22/2026 09:03:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/20/2026 10:11:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:44:04 PM
- CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones • GlobeNewswire Inc. • 01/12/2026 01:36:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2026 10:35:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2026 10:11:41 PM
- CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/05/2026 01:30:00 PM
- Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize • PR Newswire (US) • 01/02/2026 06:29:00 PM
- Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize • PR Newswire (Canada) • 01/02/2026 06:29:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 10:33:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 10:35:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/22/2025 09:20:24 PM
- CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes • GlobeNewswire Inc. • 12/16/2025 05:00:04 PM
- Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions • PR Newswire (US) • 12/09/2025 04:57:00 PM
- Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions • PR Newswire (Canada) • 12/09/2025 04:57:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 01:15:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 01:10:33 PM
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/10/2025 01:00:00 PM
- CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering • GlobeNewswire Inc. • 11/08/2025 02:56:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/04/2025 09:48:34 PM
- Intellia stock plunges after halting gene therapy trials over safety issue • IH Market News • 10/27/2025 02:35:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2025 09:35:03 PM
Metavesco Congratulates DeFi Dev Corp on Becoming the Second Publicly Traded Company to Launch a Memecoin • MVCO • Jan 22, 2026 6:04 PM
Rainmaker Worldwide Strengthens North American Growth Pipeline With Affiliate Partnership Supporting Ontario's Housing Expansion • RAKR • Jan 22, 2026 10:19 AM
From Permits to Gold Pour: Why Readiness Matters • LFLR • Jan 22, 2026 9:00 AM
Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro's 2026 Product Catalog • BLOZF • Jan 22, 2026 8:52 AM
Envirotech Vehicles Reaffirms Momentum With AZIO AI and Provides Update on Nasdaq Compliance Process • EVTV • Jan 21, 2026 1:25 PM
Rainmaker Worldwide Expands U.S. Operations With ATMOCELL 5K and R/OCell® Deployments in the Permian Basin • RAKR • Jan 20, 2026 11:15 AM

